Top

Published in:

Open Access 01-07-2013 | Original Paper

Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas

Authors: Misu Lee, Ilaria Marinoni, Martin Irmler, Tsambika Psaras, Jürgen B. Honegger, Rudi Beschorner, Natasa Anastasov, Johannes Beckers, Marily Theodoropoulou, Federico Roncaroli, Natalia S. Pellegata

Published in: Acta Neuropathologica | Issue 1/2013

Abstract

Gonadotroph adenomas comprise 15–40 % of all pituitary tumors, are usually non-functioning and are often large and invasive at presentation. Surgery is the first-choice treatment, but complete resection is not always achieved, leading to high recurrence rates. As gonadotroph adenomas poorly respond to conventional pharmacological therapies, novel treatment strategies are needed. Their identification has been hampered by our incomplete understanding of the molecular pathogenesis of these tumors. Recently, we demonstrated that MENX-affected rats develop gonadotroph adenomas closely resembling their human counterparts. To discover new genes/pathways involved in gonadotroph cells tumorigenesis, we performed transcriptome profiling of rat tumors versus normal pituitary. Adenomas showed overrepresentation of genes involved in cell cycle, development, cell differentiation/proliferation, and lipid metabolism. Bioinformatic analysis identified downstream targets of the transcription factor SF-1 as being up-regulated in rat (and human) adenomas. Meta-analyses demonstrated remarkable similarities between gonadotroph adenomas in rats and humans, and highlighted common dysregulated genes, several of which were not previously implicated in pituitary tumorigenesis. Two such genes, CYP11A1 and NUSAP1, were analyzed in 39 human gonadotroph adenomas by qRT-PCR and found to be up-regulated in 77 and 95 % of cases, respectively. Immunohistochemistry detected high P450scc (encoded by CYP11A1) and NuSAP expression in 18 human gonadotroph tumors. In vitro studies demonstrated for the first time that Cyp11a1 is a target of SF-1 in gonadotroph cells and promotes proliferation/survival of rat pituitary adenoma primary cells and cell lines. Our studies reveal clues about the molecular mechanisms driving rat and human gonadotroph adenomas development, and may help identify previously unexplored biomarkers for clinical use.

Available only for authorised users

Altenberger T, Bilban M, Auer M et al (2006) Identification of DLK1 variants in pituitary- and neuroendocrine tumors. Biochem Biophys Res Commun 340:995–1005. doi:10.1016/j.bbrc.2005.12.094 PubMedCrossRef

Anastasov N, Klier M, Koch I et al (2009) Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematopathol 2:9–19. doi:10.1007/s12308-008-0020-x CrossRef

Bogunovic D, O’Neill DW, Belitskaya-Levy I et al (2009) Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA 106:20429–20434. doi:10.1073/pnas.0905139106 PubMedCrossRef

Chen DT, Nasir A, Culhane A et al (2010) Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 119:335–346. doi:10.1007/s10549-009-0344-y PubMedCrossRef

Cheunsuchon P, Zhou Y, Zhang X et al (2011) Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 179:2120–2130. doi:10.1016/j.ajpath.2011.07.002 PubMedCrossRef

Davis SW, Castinetti F, Carvalho LR et al (2010) Molecular mechanisms of pituitary organogenesis: in search of novel regulatory genes. Mol Cell Endocrinol 323:4–19. doi:10.1016/j.mce.2009.12.012 PubMedCrossRef

Derouet-Humbert E, Roemer K, Bureik M (2005) Adrenodoxin (Adx) and CYP11A1 (P450scc) induce apoptosis by the generation of reactive oxygen species in mitochondria. Biol Chem 386:453–461. doi:10.1515/BC.2005.054 PubMedCrossRef

Doghman M, Karpova T, Rodrigues GA et al (2007) Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21:2968–2987. doi:10.1210/me.2007-0120 PubMedCrossRef

Elston MS, Gill AJ, Conaglen JV et al (2008) Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology 149:1235–1242. doi:10.1210/en.2007-0542 PubMedCrossRef

10.

Ericson J, Norlin S, Jessell TM, Edlund T (1998) Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125:1005–1015PubMed

11.

Evans CO, Young AN, Brown MR et al (2001) Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 86:3097–3107. doi:10.1210/jc.86.7.3097 PubMedCrossRef

12.

Galland F, Lacroix L, Saulnier P et al (2010) Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer 17:361–371. doi:10.1677/ERC-10-0018 PubMedCrossRef

13.

Gejman R, Batista DL, Zhong Y et al (2008) Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 93:4119–4125. doi:10.1210/jc.2007-2633 PubMedCrossRef

14.

Greenman Y, Stern N (2009) Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:625–638. doi:10.1016/j.beem.2009.05.005 PubMedCrossRef

15.

Gulzar ZG, McKenney JK, Brooks JD (2013) Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene 32:70–77. doi:10.1038/onc.2012.27 PubMedCrossRef

16.

Guo IC, Shih MC, Lan HC, Hsu NC, Hu MC, Chung BC (2007) Transcriptional regulation of human CYP11A1 in gonads and adrenals. J Biomed Sci 14:509–515. doi:10.1007/s11373-007-9177-z PubMedCrossRef

17.

Hammer F, Compagnone NA, Vigne JL, Bair SR, Mellon SH (2004) Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system. Endocrinology 145:901–912. doi:10.1210/en.2003-0125 PubMedCrossRef

18.

Hardy J (1979) The transsphenoidal surgical approach to the pituitary. Hosp Pract 14:81–89PubMed

19.

Hussaini IM, Trotter C, Zhao Y et al (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356–365. doi:10.2353/ajpath.2007.060736 PubMedCrossRef

20.

Ikuyama S, Mu YM, Ohe K et al (1998) Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas. Clin Endocrinol 48:647–654. doi:10.1046/j.1365-2265.1998.00477.x CrossRef

21.

Iyer J, Moghe S, Furukawa M, Tsai MY (2011) What’s Nu(SAP) in mitosis and cancer? Cell Signal 23:991–998. doi:10.1016/j.cellsig.2010.11.006 PubMedCrossRef

22.

Jiang Z, Gui S, Zhang Y (2012) Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays. J Neurooncol 108:341–348. doi:10.1007/s11060-011-0792-1 PubMedCrossRef

23.

Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30:790–829. doi:10.1210/er.2009-0008 PubMedCrossRef

24.

Lee M, Theodoropoulou M, Graw J, Roncaroli F, Zatelli MC, Pellegata NS (2011) Levels of p27 sensitize to dual PI3 K/mTOR inhibition. Mol Cancer Ther 10:1450–1459. doi:10.1158/1535-7163.MCT-11-0188 PubMedCrossRef

25.

Machiavelli GA, Rivolta CM, Artese R, Basso A, Burdman JA (1998) Expression of c-myc and c-fos and binding sites for estradiol and progesterone in human pituitary tumors. Neurol Res 20:709–712PubMed

26.

Marinoni I, Lee M, Mountford S et al (2013) Characterization of MENX-associated pituitary tumours. Neuropathol Appl Neurobiol 39:256–269. doi:10.1111/j.1365-2990.2012.01278.x PubMedCrossRef

27.

Melmed S (2011) Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7:257–266. doi:10.1038/nrendo.2011.40 PubMedCrossRef

28.

Michaelis KA, Knox AJ, Xu M et al (2011) Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology 152:3603–3613. doi:10.1210/en.2011-0109 PubMedCrossRef

29.

Molatore S, Kiermaier E, Jung CB et al (2010) Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors. Mol Cancer 9:116. doi:10.1186/1476-4598-9-116 PubMedCrossRef

30.

Molatore S, Liyanarachchi S, Irmler M et al (2010) Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma. Proc Natl Acad Sci USA 107:18493–18498. doi:10.1073/pnas.1003956107 PubMedCrossRef

31.

Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65:10214–10222. doi:10.1158/0008-5472.CAN-05-0884 PubMedCrossRef

32.

Morris DG, Musat M, Czirjak S et al (2005) Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol/Eur Fed Endocr Soc 153:143–151. doi:10.1530/eje.1.01937 CrossRef

33.

Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558–15563. doi:10.1073/pnas.0603877103 PubMedCrossRef

34.

Pereira AM, Biermasz NR (2012) Treatment of nonfunctioning pituitary adenomas: what were the contributions of the last 10 years? A critical view. Ann Endocrinol 73:111–116. doi:10.1016/j.ando.2012.04.002 CrossRef

35.

Raemaekers T, Ribbeck K, Beaudouin J et al (2003) NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J Cell Biol 162:1017–1029. doi:10.1083/jcb.200302129 PubMedCrossRef

36.

Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z (2006) CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res 34:W498–W503. doi:10.1093/nar/gkl038 PubMedCrossRef

37.

Scheithauer BW, Kovacs K, Zorludemir S, Lloyd RV, Erdogan S, Slezak J (2008) Immunoexpression of androgen receptor in the nontumorous pituitary and in adenomas. Endocr Pathol 19:27–33. doi:10.1007/s12022-007-9012-0 PubMedCrossRef

38.

Teplyuk NM, Zhang Y, Lou Y et al (2009) The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 23:849–861. doi:10.1210/me.2008-0270 PubMedCrossRef

39.

Ueta Y, Levy A, Powell MP et al (1998) Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression. Clin Endocrinol 49:29–38. doi:10.1046/j.1365-2265.1998.00399.x CrossRef

40.

Val P, Martinez-Barbera JP, Swain A (2007) Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134:2349–2358. doi:10.1242/dev.004390 PubMedCrossRef

41.

Vigneron S, Prieto S, Bernis C, Labbe JC, Castro A, Lorca T (2004) Kinetochore localization of spindle checkpoint proteins: who controls whom? Mol Biol Cell 15:4584–4596. doi:10.1091/mbc.E04-01-0051 PubMedCrossRef

42.

Wang SM, Ooi LL, Hui KM (2011) Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res: Off J Am Assoc Cancer Res 17:6040–6051. doi:10.1158/1078-0432.CCR-11-0557 CrossRef

43.

Wierinckx A, Auger C, Devauchelle P et al (2007) A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer 14:887–900. doi:10.1677/ERC-07-0062 PubMedCrossRef

44.

Yao X, Abrieu A, Zheng Y, Sullivan KF, Cleveland DW (2000) CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat Cell Biol 2:484–491. doi:10.1038/35019518 PubMedCrossRef

45.

Zhan X, Desiderio DM (2010) Signaling pathway networks mined from human pituitary adenoma proteomics data. BMC Med Genomics 3:13. doi:10.1186/1755-8794-3-13 PubMedCrossRef

46.

Zou H, McGarry TJ, Bernal T, Kirschner MW (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285:418–422. doi:10.1126/science.285.5426.418 PubMedCrossRef

Title: Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
Authors: Misu Lee
Ilaria Marinoni
Martin Irmler
Tsambika Psaras
Jürgen B. Honegger
Rudi Beschorner
Natasa Anastasov
Johannes Beckers
Marily Theodoropoulou
Federico Roncaroli
Natalia S. Pellegata
Publication date: 01-07-2013
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 1/2013
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-013-1132-7

At a glance: The STEP trials

Springer Medicine

Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation

Globular glial-like inclusions in a patient with advanced Alzheimer’s disease

Mild traumatic brain injury in the mouse induces axotomy primarily within the axon initial segment

Charcot–Marie–Tooth causing HSPB1 mutations increase Cdk5-mediated phosphorylation of neurofilaments

Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy